Cargando…

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age

BACKGROUND: Medical and public health importance of pneumococcal infections justifies the implementation of measures capable of reducing their incidence and severity, and explains why the recently marketed heptavalent pneumococcal conjugate vaccine (PCV-7) has been widely studied by pediatricians. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Susanna, Lizioli, Alessandro, Lastrico, Annalisa, Begliatti, Enrica, Rognoni, Alessandro, Tagliabue, Claudia, Cesati, Laura, Carreri, Vittorio, Principi, Nicola
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804265/ https://www.ncbi.nlm.nih.gov/pubmed/17313667 http://dx.doi.org/10.1186/1465-9921-8-12

Ejemplares similares

Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine
por: Esposito, Susanna, et al.
Publicado: (2016)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine
por: Marchisio, Paola, et al.
Publicado: (2002)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
por: Rückinger, Simon, et al.
Publicado: (2010)

Effectiveness and cost-effectiveness of general immunisation of infants and young children with the heptavalent conjugated pneumococcal vaccine
por: Antony, Katja, et al.
Publicado: (2005)

Antimicrobial Resistance among Isolates Causing Invasive Pneumococcal Disease before and after Licensure of Heptavalent Conjugate Pneumococcal Vaccine
por: Karnezis, Tom Theodore, et al.
Publicado: (2009)

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
por: Esposito, Susanna, et al.
Publicado: (2015)

Biofilm-Forming Bacteria Implicated in Complex Otitis Media in Children in the Post-Heptavalent Pneumococcal Conjugate Vaccine (PCV7) Era
por: Ioannidis, Anastasios, et al.
Publicado: (2023)

Use of 13-valent pneumococcal conjugate vaccine in children older than 5 years of age
por: Principi, Nicola, et al.
Publicado: (2014)

Sortase-click strategy for defined protein conjugation on a heptavalent cyclodextrin scaffold
por: Singh, Shikha, et al.
Publicado: (2019)

Association between high nasopharyngeal viral load and disease severity in children with human metapneumovirus infection
por: Bosis, Samantha, et al.
Publicado: (2008)

Decrease in Hospitalizations for Pneumonia in Children under Five Years of Age in an Indian Reservation in Panama after the Introduction of the Heptavalent Pneumococcal Conjugate Vaccine (PCV7)
por: Nieto Guevara, Javier, et al.
Publicado: (2013)

Pneumococcal vaccination in children with underlying conditions
por: Principi, Nicola, et al.
Publicado: (2015)

Pneumococcal Disease Prevention: Are We on the Right Track?
por: Principi, Nicola, et al.
Publicado: (2021)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
por: Principi, Nicola, et al.
Publicado: (2016)

Novel β-Cyclodextrin-Based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity
por: Liang, Shuobin, et al.
Publicado: (2022)

Pneumococcal colonization in older adults
por: Esposito, Susanna, et al.
Publicado: (2016)

Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product
por: Anderson, Deborah M., et al.
Publicado: (2019)

Kinetics and mechanistic investigations on antiviral drug-valacyclovir hydrochloride by heptavalent alkaline permanganate
por: Tuwar, Suresh M, et al.
Publicado: (2021)

Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
por: Beliveau, Martin, et al.
Publicado: (2022)

A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
por: Esposito, Susanna, et al.
Publicado: (2019)

Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
por: Syrogiannopoulos, George A., et al.
Publicado: (2021)

Do children’s upper respiratory tract infections benefit from probiotics?
por: Esposito, Susanna, et al.
Publicado: (2014)

Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2020)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly
por: Seo, Yu Bin, et al.
Publicado: (2017)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants
por: Jones, Stephanie A., et al.
Publicado: (2013)

Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs
por: Barker, Douglas, et al.
Publicado: (2019)

Assessment of the potency and effectiveness of a heptavalent oil-adjuvanted (ISA 206) foot-and-mouth disease vaccine in Egypt
por: Bazid, Abdel-Hamid, et al.
Publicado: (2023)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020)

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy
por: Castiglia, Paolo, et al.
Publicado: (2017)

Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study
por: Esposito, Susanna, et al.
Publicado: (2019)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Pneumococcal Conjugate Vaccines and Otitis Media
por: Taylor, Sylvia, et al.
Publicado: (2012)

Strengths and weaknesses of pneumococcal conjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2023)

Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia
por: Esposito, Susanna, et al.
Publicado: (2015)

Epidemiology and Clinical Characteristics of Respiratory Infections Due to Adenovirus in Children Living in Milan, Italy, during 2013 and 2014
por: Esposito, Susanna, et al.
Publicado: (2016)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
por: Fortunato, Francesca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0fgroo1pahoebokvunqnm267qj